EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Chinese patent medicine Tongxinluo: A review on chemical constituents, pharmacological activities, quality control, and clinical applications

Qin Chen, Junbo Zou, Yajun Shi, Xiaofei Zhang, Dongyan Guo, Fei Luan, Jing Sun

Phytomedicine · 2024

DOI: 10.1016/j.phymed.2024.155674 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Phytomedicine, 2024. Verfasst von Qin Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research, Shaanxi University of Chinese Medicine, Xi'an 712046, Shaanxi, PR Chi…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Quality Control, Cardiovascular Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 162 Literaturangaben. Gefördert von: Inner Mongolia Autonomous Region Department of Science and Technology, Shaanxi University of Chinese Medicine, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cardiovascular and cerebrovascular disease (CCVD) is the leading cause of morbidity and mortality worldwide, imposing a significant economic burden on individuals and societies. For the past few years, Traditional Chinese Medicine (TCM) has attracted much attention due to its advantages such as fewer side effects in the treatment of CCVD. TXL has shown great promise in the treatment of CCVD. PURPOSE: This paper aims to provide a comprehensive introduction to TXL, covering its chemical constituents, quality control, pharmacological properties, adverse reactions, and clinical applications through an extensive search of relevant electronic databases while discussing its current challenges and provides opinions for future study. METHODS: The following electronic databases were searched up to 2023: "TXL", "CCVD", "Chemical constituents", "Quality control" and "Pharmacological properties" were entered as keywords in PubMed, Web of Science, Google Scholar and China National Knowledge Infrastructure Database and WANFANG DATA databases. The PRISMA guidelines were followed in this review process. RESULTS: Studies have confirmed that TXL is effective in treating patients with CCVD and has fewer adverse effects. The aim of this review is to explore TXL anti-CCVD effects in relation to oxidative stress, lipid metabolism and enhanced cardiac function. This review also provides additional information on safety issues. CONCLUSION: TXL plays a key role in the treatment of CCVD by regulating various pathways such as lipid metabolism, oxidative stress and inflammation. However, further clinical trials and animal experiments are needed to provide more evidence and recommendations for its clinical application. This article provides an overview of TXL research to inform and inspire future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalQuality ControlCardiovascular DiseasesHumansMedicine, Chinese TraditionalAnimalsCerebrovascular DisordersOxidative Stress

Stichwörter der Autor:innen

Cardiovascular and cerebrovascular diseases (CCVD)Chemical constituentsClinical applicationPharmacological propertiesQuality controlTongxinluo (TXL)

Substanzen

Drugs, Chinese Herbaltongxinluo

Autor:innen und Institutionen

  • Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research, Shaanxi University of Chinese Medicine, Xi'an 712046, Shaanxi, PR China; School of Pharmacy, Shaanxi University of Chinese Medicine, Xi'an…

Förderung

  • Inner Mongolia Autonomous Region Department of Science and Technology
  • Shaanxi University of Chinese Medicine
  • National Natural Science Foundation of China
  • Education Department of Shaanxi Provincial government
  • National Key Research and Development Program of China

Zitieren

APA

Chen, Q., Zou, J., Shi, Y., Zhang, X., Guo, D., Luan, F., & Sun, J. (2024). Chinese patent medicine Tongxinluo: A review on chemical constituents, pharmacological activities, quality control, and clinical applications. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.155674

Vancouver

Chen Q, Zou J, Shi Y, Zhang X, Guo D, Luan F, et al. Chinese patent medicine Tongxinluo: A review on chemical constituents, pharmacological activities, quality control, and clinical applications. Phytomedicine. 2024. doi:10.1016/j.phymed.2024.155674

BibTeX
@article{Chen2024,
  author = {Chen, Qin and Zou, Junbo and Shi, Yajun and Zhang, Xiaofei and Guo, Dongyan and Luan, Fei and Sun, Jing},
  title = {Chinese patent medicine Tongxinluo: A review on chemical constituents, pharmacological activities, quality control, and clinical applications},
  journal = {Phytomedicine},
  year = {2024},
  doi = {10.1016/j.phymed.2024.155674}
}
Kostenlos starten →